Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shohei Mitsuyasu
The Augmented Expression of the Cytidine Deaminase Gene by 5-Azacytidine Predicts Therapeutic Efficacy in Myelodysplastic Syndromes
Oncotarget
Oncology
Related publications
Role of BCL2L10 Methylation and TET2 Mutations in Higher Risk Myelodysplastic Syndromes Treated With 5-Azacytidine
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Global Gene Expression Profile in Myelodysplastic Syndromes Using SAGE
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
The Prognostic Significance of Chromosome 17 Abnormalities in Patients With Myelodysplastic Syndrome Treated With 5‐azacytidine: Results From the Hellenic 5‐azacytidine Registry
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
The Myelodysplastic Syndromes
Emerging Cancer Therapeutics
The Myelodysplastic Syndromes
Oncologist
Cancer Research
Medicine
Oncology
528. Transgenic Expression of Cytidine Deaminase (CDD) for Myeloprotective Purposes
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Methylation and Expression of Mismatch Repair Gene Human mutS Homolog 2 in Myelodysplastic Syndromes
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Understanding the Myelodysplastic Syndromes
Oncologist
Cancer Research
Medicine
Oncology
Myelodysplastic Syndromes
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
